Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 1/20 | 0.33 |
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21134125 | 0.87 | CCR6 (0.34) | CCR6 | |
| SCHEMBL11236325 | 0.84 | CCR6 (0.38) | CCR6 | |
| SCHEMBL11236329 | 0.84 | CCR6 (0.38) | CCR6 | |
| SCHEMBL27244325 | 0.76 | MAP1LC3B (0.33) | MAP1LC3BLMNAMAPTCYP2C9ALOX15 | |
| SCHEMBL21134123 | 0.76 | MAP1LC3B (0.33) | MAP1LC3BLMNAMAPTCYP2C9ALOX15 | |
| SCHEMBL27244359 | 0.76 | MAP1LC3B (0.33) | MAP1LC3BLMNAMAPTCYP2C9ALOX15 | |
| SCHEMBL27244319 | 0.76 | MAP1LC3B (0.33) | MAP1LC3BLMNAMAPTCYP2C9ALOX15 | |
| SCHEMBL24312359 | 0.74 | POLL (0.33) | MAP1LC3BLMNAMAPTCYP2C9ALOX15 | |
| SCHEMBL30989575 | 0.72 | MAP1LC3B (0.30) | MAP1LC3BLMNAMAPTCYP2C9ALOX15 | |
| SCHEMBL26617703 | 0.69 | CA1 (0.38) | MAP1LC3BLMNAMAPTCYP2C9ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118215654-A | AHR agonists | 伊莱利利公司 | 2024-06-18 | — | — | CN | disclosed |